Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...

Arch Capital Group is rated a Buy, contingent on maintaining profitability and book value growth amid declining reinsurance ...

Deep Fission’s borehole nuclear model: catalysts, DOE pilot path, LOI pipeline, and IPO weakness—plus key PWR/LEU risks.

(RNS) — For many evangelicals, Israel is not just a sign of the End Times. It is also the homeland of a people they believe ...

Obicetrapib, a cholesterol-lowering drug already in Phase 3 cardiovascular trials, significantly reduced a validated ...